Brief: Psyence And Filament Health Announce Worldwide Licensing Agreement Of Psilocybin Capsule For Palliative Care
15/12/2022 15:05
Dec 15 (Reuters) - Filament Health Corp FH.NLB :
* PSYENCE AND FILAMENT HEALTH ANNOUNCE WORLDWIDE LICENSING
AGREEMENT OF PSILOCYBIN CAPSULE FOR PALLIATIVE CARE
* FILAMENT HEALTH - DEAL GRANTS PSYENCE WORLDWIDE RIGHT TO
COMMERCIALIZE CO'S PEX010, WITHIN CONTEXT OF PALLIATIVE CARE
Source text for Eikon: ID:nGNX3wJXH6
Further company coverage: FH.NLB
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Psyence
See all newsBrief: Psyence Group To Consolidate Shares 15 To 1 Effective April 23, 2025
Brief: Psyence Group Enters Into Debt-For-Equity Swap Agreement With Its Nasdaq-Listed Associate, Psyence Biomedical
Brief: Psyence Biomed Enters Into Agreement To Acquire Stake In Psylabs
Brief: Psyence Biomedical Ltd. Approved To List On Nasdaq Following Completion Of Business Combination Agreement With Newcourt Acquisition Corp
MGC Pharmaceuticals - September 2023 Quarter Activity Report